BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10930119)

  • 1. Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice.
    Moore AB; He H; Yoshida A; Rico PJ; Haseman JK; Dixon D
    Exp Toxicol Pathol; 2000 Jun; 52(3):195-200. PubMed ID: 10930119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.
    Shimomura Y; Matsuo H; Samoto T; Maruo T
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2192-8. PubMed ID: 9626159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of VEGF, VEGF receptors, EGF-R and Ki-67 in leiomyoma, cellular leiomyoma and leiomyosarcoma.
    Sanci M; Dikis C; Inan S; Turkoz E; Dicle N; Ispahi C
    Acta Histochem; 2011 May; 113(3):317-25. PubMed ID: 20106509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium.
    Dixon D; He H; Haseman JK
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():795-802. PubMed ID: 11035985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.
    Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert AD; D'Antonio A; Losito S; Normanno N; Salomon DS
    J Pathol; 2007 Jan; 211(1):36-44. PubMed ID: 17072826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in surgically induced endometriosis in rats.
    Simms JS; Chegini N; Williams RS; Rossi AM; Dunn WA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):850-7. PubMed ID: 1923211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats.
    Madtes DK; Busby HK; Strandjord TP; Clark JG
    Am J Respir Cell Mol Biol; 1994 Nov; 11(5):540-51. PubMed ID: 7524566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of transforming growth factor alpha (TGF alpha), epidermal growth factor receptor (EGF-R) and cell proliferation during human palatogenesis: an immunohistochemical study.
    Citterio HL; Gaillard DA
    Int J Dev Biol; 1994 Sep; 38(3):499-505. PubMed ID: 7848833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the ERα/ERβ ratio and neurotensin and its high-affinity receptor in myometrium, uterine leiomyoma, atypical leiomyoma, and leiomyosarcoma.
    Rodríguez Y; Báez D; de Oca FM; García C; Dorta I; Reyes R; Valladares F; Almeida TA; Bello AR
    Int J Gynecol Pathol; 2011 Jul; 30(4):354-63. PubMed ID: 21623207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES).
    Newbold RR; Moore AB; Dixon D
    Toxicol Pathol; 2002; 30(5):611-6. PubMed ID: 12371671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferation and apoptosis in human uterine leiomyomas and myometria.
    Dixon D; Flake GP; Moore AB; He H; Haseman JK; Risinger JI; Lancaster JM; Berchuck A; Barrett JC; Robboy SJ
    Virchows Arch; 2002 Jul; 441(1):53-62. PubMed ID: 12111201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells.
    Zhu XQ; Lv JQ; Lin Y; Xiang M; Gao BH; Shi YF
    Gynecol Oncol; 2007 Jun; 105(3):650-6. PubMed ID: 17368523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
    Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
    Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
    Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S; Nakano H; Tsuneyoshi M
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
    Jeffers MD; Richmond JA; Macaulay EM
    Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.